KEVIN BONFIELD: Open Payments
NPI 1285096354 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 24 payments from 13 companies in 2025. Trend: 2023 $621 · 2024 $576 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $92 |
| ABBVIE INC. | 3 | $55 |
| Amgen Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| PFIZER INC. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: Wegovy, ELIQUIS, CAPLYTA, QULIPTA, Rybelsus, OTEZLA, TRELEGY ELLIPTA, CAMZYOS.
Industry payments across KY — which companies pay providers there.
